Диссертация (1139571), страница 34
Текст из файла (страница 34)
Lukac, R. A. Bonomo, L. K. Logan //Healthcare epidemiology. – 2015. – Vol. 60. – P. 1389–1397.255. Maiden, M.C. Multilocus sequence typing: a portable approach to theidentification of clones within populations of pathogenic microorganisms / M.C.Maiden, J.A. Bygraves, E. Feil, G. Morelli, et al. // Proceedings of the NationalAcademy of Sciences. – 1998. – Vol.
95. – P. 3140-5.217256. Malhotra-Kumar, S. Effect of azithromycin and clarithromycin the therapypharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: arandomized, double-blind, placebo-controlled study / S. Malhotra-Kumar., C.Lammens, K. Herck Van, H. Goossens // The Lancet. – 2007. – Vol.369, № 10. –P. 482-90.257. Mano, Y. Molecular analysis of the integrons of metallo-β-lactamase-producingPseudomonas aeruginosa isolates collected by nationwide surveillance programsacross Japan / Y.
Mano, T. Saga, Y. Ishii, A. Yoshizumi et al. // BMCMicrobiology. – 2015. – Vol.21. – P.15:41.258. Mansoor, T. Pseudomonas aeruginosa in chronic suppurative otitis media:Sensitivity spectrum against various antibiotics in Karachi / T. Mansoor, M. A.Musani, G. Khalid, M. Kamal // Ayub Medical College. – 2009. – Vol. 21, №. 2. –P. 120-123.259. Martinovich, A. Ten-years resistance trends of nosocomial Acinetobacter spp. InRussia / A.
Martinovich, N. Ivanchik, O. Kretchikova, G. Reshedko G et al. //19th European Congress of Clinical Microbiology and Infections Diseases. –2009. – Helsinki, Finland. Abstract P 1717.260. May, T. B. Alginate synthesis by Pseudomonas aeruginosa: a key pathogenicfactor in chronic pulmonary infections of cystic fibrosis patients / T. B. May, D.Shinabarger, R. Maharaj, J. Kato et al // Clinical microbiology reviews. – 1991.
–Vol. 4, №. 2. – P. 191-206.261. Mayanskiy, N. Serotypes and antibiotic resistance of non-invasive Streptococcuspneumoniae circulating in pediatric hospitals in Moscow, Russia / N. Mayanskiy,N. Alyabieva, O. Ponomarenko, et al. // The Journal of Infectious Diseases. –2014. – Vol.
20. – P. 58-62.262. Mayanskiy, N. Bacterial etiology of acute otitis media and characterization ofpneumococcal serotypes and genotypes among children in Moscow, Russia / N.Mayanskiy, N. Alaybieva N, O. Ponomarenko et al. // The Pediatric InfectiousDisease Journal. – 2015. – Vol. 34. – P. 255-60.218263. Mayanskiy, N.A. MALDI-TOF mass spectrometry in the clinical microbiologylaboratory everyday work / N.A. Mayanskiy, A.N.
Kalakutskaya, O.V. Motuzova,G.G. Lominadze, et al. // Voprosy diagnostiki v pediatrii. – 2011. – Vol. 3, №5. –P. 20-25.264. Mayr, F.B. Epidemiology of severe sepsis / F.B. Mayr, S. Yende, D.C. Angus //Virulence. – 2014. – Vol. 5, № 1. – P. 4-11.265. MacDougall, C. Antimicrobial stewardship programs in health care systems / C.MacDougall, R.E.
Polk // Clinical Microbiology Reviews – 2008. – Vol. 18, № 4.– P. 638-56.266. McElligott, M. Noninvasive pneumococcal clones associated with antimicrobialnonsusceptibility isolated from children in the era of conjugate vaccines / M.McElligott, I. Vickers, M. Meehan, et al. // Antimicrobial Agents andChemotherapy. – 2015.
– Vol. 59. – P. 5761-5767.267. McGee, L. Nomenclature of major antimicrobial-resistant clones ofStreptococcus pneumoniae defined by the pneumococcal molecular epidemiologynetwork / L. McGee, L. Mcdougal, J. Zhou, B.G. Spratt et al. // Journal of ClinicalMicrobiology. – 2001. – Vol. 39. – P. 2565-2571.268. McQueary, C.N. Acinetobacter baumannii biofilms: variations among strainsand correlations with other cell properties / C.N.
McQueary, L.A. Actis // Journalof Clinical Microbiology. – 2011. Vol. 49, № 2. – P. 243–250.269. Mermel, L.A. Clinical Practice Guidelines for the Diagnosis and Management ofIntravascular Catheter-Related Infection: 2009 Update by the Infection diseasesSociety of America. IDSA Guidelines for Intravascular Catheter-Related Infection/ L.A.
Mermel, M. Allon, E. Bouza, D.E. Graven, et al. // Clinical InfectiousDiseases. – 2009. – Vol. 49. – P.1-5.270. Metcalf, B. Strain features and distributions in pneumococci from children withinvasive disease before and after13-valent conjugate vaccine implementation inthe USA / B. Metcalf, R. Jr. Gertz., R.
Gladstone, et al. // Journal of ClinicalMicrobiology. – 2016. – Vol. 22, № 1. – P. 60.219271. Mittal, R. Urinary tract infections caused by Pseudomonas aeruginosa: аminireview / R. Mittal, S. Aggarwal, S. Sharma, S. Chhibber et al // Journal ofinfection and public health. – 2009. – Vol.
2, № 3. – P. 101-111.272. Molnar, Z. Timing IgM treatment in sepsis: is procalcitonin the answer& in:Annual update in intensive care and emergency medicine 2012 / Z. Molnar, J.Fogas J. Edited by J.-L. Vincept. – 2012. – P. 109-115.273. Moore, M. Effectiveness of 13-valent pneumococcal conjugate vaccine forprevention of invasive pneumococcal disease in children in the USA: a matchedcase-control study / M. Moore, R.
Link-Gelles, W. Schaffner, et al. // The LancetRespiratory Medicine. – 2016. – Vol. 4. – P.399-406.274. Moore, M.R. Population snapshot of emergent Streptococcus pneumoniaeserotype 19A in the United States, 2005 / M.R. Moore, R.E. Jr Gertz, R.L.Woodbury, et al. // The Journal of Infectious Diseases. – 2008. – Vol. 197. –P.1016-27.275. Morales, D. K.
Control of Candida albicans metabolism and biofilm formationby Pseudomonas aeruginosa phenazines / D. K. Morales, N. Grahl, C. Okegbe, L.E. Dietrich et al // MBio. – 2013. – Vol. 4, № 1. – P. e00526-12.276. Morrill, H.J. Treatment Options for Carbapenem-Resistant EnterobacteriaceaeInfections / H.J. Morrill, J.M. Pogue, K.S.
Kaye, K.L. LaPlante // Open ForumInfectious Diseases. – 2015. – Vol. 5, № 2. – P. 2.277. Müller, S. Green Nail Syndrome (Pseudomonas aeruginosa Nail Infection): TwoCases Successfully Treated with Topical Nadifloxacin, an Acne Medication / S.Müller, M. Ebnöther, P. Itin // Case reports in dermatology. – 2014. – Vol. 6, № 2.– P. 180278. Multilocus sequence typing: Streptococcus pneumoniae [database online].Available at: http://pubmlst.org/spneumoniae.279. Munoz-Price, L.S. Eighteen years of experience with Acinetobacter baumanniiin a tertiary care hospital. Crit / L.S.
Munoz-Price, K. Arheart, P. Nordmann, A.E.Boulanger, et al. // Critical Care Medicine. – 2013. – Vol. 41. – P. 2733-42.220280. Naas, T. Multidrug-resistant Acinetobacter baumannii, Russia / T.Naas, S.Kernbaum, S. Allali, P. Nordmann // Emerging Infectious Diseases. – 2007. –Vol. 13. – P. 669-71.281. Nadel, D.M. Endoscopically guided cultures in chronic sinusitis / D.M. Nadel,D.C. Lanza, D.W. Kennedy // American Journal of Rhinology . – 1998. Vol.
12. –P. 233–241.282. National Nosocomial Infections Surveillance (NNIS) System Report. AmericanJournal of Infection Control. – 2004. – Vol. 32. – P. 470–85.283. Nemec, A. Long-term predominance of two pan-European clones among multiresistant Acinetobacter baumannii strains in the Czech Republic / A. Nemec, L.Dijkshoorn, T.J. van der Reijden // Journal of Medical Microbiology.
– 2004. –Vol. 53. – P. 147–153.284. Nseir, S. Impact of appropriate antimicrobial treatment on transition fromventilator-associated tracheobronchitis to ventilator-associated pneumonia / S.Nseir, I. Martin-Loeches, D. Makris, E. Jaillette et al // Crit Care. – 2014. – Vol.18, № 3. – P. R129.285. Obert, C.A. Assessment of molecular typing methods to determine invasivenessand to differentiate clones of Streptococcus pneumoniae / C.A. Obert, G.
Gao, J.Sublett, E.I. Tuomanen, et al. // Infection, Genetics and Evolution. – 2007. – Vol.7. – P. 708-716.286. OˈGraby, N.P. Healthcare Infection Control Practices Advisory Committee.Guidelines for the prevention of intravascular catheter-related infections / N.P.OˈGraby, M. Alexander, L.A. Burns, et al. // American Journal of InfectionControl. – 2011.
– Vol.39. – P. 1-34.287. O'Toole, G.A. Genetic approaches to study of biofilms / G.A. O'Toole, L.A.Pratt, P.I. Watnick, D.K. Newman, et al. // Methods in Enzymolog – 1999. – Vol.310. – P. 91-109.288. Oteo, J. The spread of KPC-producing Enterobacteriaceae in Spain: WGSanalysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2,ST101/KPC-2 and ST512/KPC-3 / J.
Oteo, M. Pérez-Vázquez, V. Bautista, A.221Ortega, et al. // The Journal of Antimicrobial Chemotherapy. – 2016. – Vol. 71, №12. – P. 3392-3399.289. Pai, R. Clonal association between Streptococcus pneumoniae serotype 23A,circulating within the United States, and an internationally dispersed clone ofserotype 23F // R. Pai, R.E. Gertz, C.G. Whitney, B. Beall // The Journal ofClinical Microbiology. – 2005. – Vol. 43, № 11. – P.
5440-4.290. Pai, R. Sequential multiplex PCR approach for determining capsular serotypesof Streptococcus pneumoniae isolates // R. Pai, R.E. Gertz, B.J. Beall // TheJournal of Clinical Microbiology. – 2006. – Vol. 44. – P.124 –13.291. Papagiannitsis, C.C. Molecular Characterization of Carbapenemase-ProducingPseudomonas aeruginosa of Czech Origin and Evidence for Clonal Spread ofExtensively Resistant Sequence Type 357 Expressing IMP-7 Metallo-βLactamase / C.C.
Papagiannitsis, M. Medvecky, K. Chudejova, A. Skalova, et. al.// Antimicrobial Agents and Chemotherapy. – 2017. – Vol. 22. – P. e01811-17.292. Pastar, I. Interactions of methicillin resistant Staphylococcus aureus USA300and Pseudomonas aeruginosa in polymicrobial wound infection / I. Pastar, A. G.Nusbaum, J. Gil, S. B. Patel et al // PloS one. – 2013. – Vol. 8, № 2. – P. e56846.293. Paul, M. Combination antimicrobial treatment versus monotherapy: thecontribution of meta-analyses / M.
Paul, L. Leibovici // Infectious disease clinicsof North America. – 2009. – Vol. 23, № 2. – P. 277-293.294. Pelton, S.I. Emergence of 19A as virulent and multidrug resistantPneumococcus in Massachusetts following universal immunization of infants withpneumococcal conjugate vaccine / S.I.
Pelton, H. Huot, J.A. Finkelstein, C.J.Bishop, et al. // The Pediatric Infectious Disease Journal. – 2007. – Vol. 26. – P.468–72.295. Pena, C. Influence of virulence genotype and resistance profile in the mortalityof Pseudomonas aeruginosa bloodstream infections / C. Pena, G. Cabot, S.Gomez-Zorrilla, L. Zamorano et al // Clinical Infectious Diseases. – 2014: ciu866.222296. Pendleton, J.N. Clinical relevance of the ESCAPE Pathogens / J.N. Pendleton,S.P.